Will Watchman Prevail With FDA? Boston Scientific’s LAA Closure Trial Raises Questions, Controversy

The PREVAIL study of Boston Scientific’s Watchman left atrial appendage (LAA) closure device was primarily positive, but will it be enough to win FDA approval for the device?

More from Archive

More from Medtech Insight